Drugs / Faecal microbiota
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07639177 | Jun 2026 → Jun 2028 expected | rheumatoid arthritis | Peking Union Medical College Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Faecal microbiota | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07639177 ↗ |
| Modality | Other / unclassified | “lyophilised oral capsules with faecal microbiota” NCT07639177 ↗ |
| Route | Oral | “lyophilised and prepared into oral capsule” NCT07639177 ↗ |